Pierce Protein A/G Agarose

SECTION 2: Hazards identification

Directive 1999/45/EC: Physical state : Liquid. [Gelatinous precipitate.]

Potential Acute Health Effects

Inhalation : Irritating to respiratory system. Ingestion : No known significant effects or critical hazards. Skin : Irritating to skin. Eyes : Severely irritating to eyes. Risk of serious damage to eyes. Potential chronic health effects

Potential chronic health

Contains material that can cause target organ damage. Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards.

Teratogenic Effects

Contains material which can cause birth defects. Developmental effects : Contains material which can cause developmental abnormalities. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which causes damage to the following organs: kidneys, the nervous system, heart. Contains material which may cause damage to the following organs: blood, the reproductive system, liver, upper respiratory tract, skin, central nervous system (CNS), eye, lens or cornea. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions aggravated by over- exposure : Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be aggravated by over-exposure to this product. The preparation is not classified as dangerous according to Directive 1999/45/EC and its amendments.

2.1 Classification of the substance or mixture

Not classified. See toxicological information (section 11)